Call for Abstracts

• Abstract presentations are scheduled at the sole discretion of the APSS Program Committee. Submission of an abstract constitutes the commitment of at least one author to present the abstract as accepted, regardless of presentation type or day/time assigned.
• Expenses associated with the preparation, submission and presentation of an abstract are the responsibility of the author/presenter.
• Abstract presenters must register for the meeting. Registration instructions for the meeting will be included with the notice of acceptance.
• Case reports and literature reviews are not appropriate and will not be considered. Click here for information about case report submissions.
• Abstracts will not be accepted for presentation if they fail to reflect acceptable scientific methodology, if the data or statistical analyses do not justify the conclusions, if they lack sufficient scientific or clinical merit or if no data are included.
• All abstracts are peer-reviewed; notice of acceptance will be sent to the contact author via email in February 2021.

Abstracts that do not meet all of the specifications listed below will be automatically rejected:

• An individual may be the first author on a maximum of two abstracts.
• There can be no more than fifteen (15) authors per abstract.
• Abstracts must conform to the following outline. Abstract sections may not be substituted with different terminology:
  • Title
  • Authors and Institutions
  • Introduction
  • Methods
  • Results
  • Conclusion
  • Support (if any)
• The abstract body (including introduction, methods, results, conclusion, and support) is limited to 350 words.
• Brand names may not be used in abstract titles and are limited to one reference within the body.
• References, tables, figures or any other graphics are not permitted.

• All abstracts must be submitted electronically via the SLEEP 2021 website.
• Authors are encouraged to submit abstracts early. You will be able to revise, edit and preview your abstract until the close date of December 28, 2020 at 11:59 p.m. EST.
• Please review your work for accuracy; abstracts will be printed exactly as submitted. Due to the high number of abstracts anticipated, copyediting of your abstract will not be permitted.
• To withdraw an abstract, the contact author of the abstract must provide written notification to the APSS Meeting Department by March 5, 2021.
• A nonrefundable abstract review fee of $50.00 per submission must be paid at the time of submission. Review fees are non-refundable for withdrawn abstracts.

Authors are required to write an original abstract that fulfills accepted criteria for copyright purposes. Accepted abstracts will be published and copyrighted in a special issue of the journal SLEEP. By submitting an abstract, all authors attest that the abstract submitted has not been previously published elsewhere and transfers, assigns, or otherwise conveys all copyright ownership, including any and all rights incidental thereto, exclusively to the Sleep Research Society as publisher of the journal SLEEP.

If an author chooses to submit information from an abstract that has previously been presented and/or published, all data must be updated, current, and rewritten in a manner that does not infringe on copyright laws. Authors are responsible for obtaining permission to include any copyrighted material in their abstract presentations. All authors will be required to agree to a copyright assignment statement when submitting an abstract.

The Program Committee will give priority to research that has not been presented elsewhere or published prior to SLEEP 2021.

The American Academy of Sleep Medicine offers the AASM Trainee Investigator Award. Application information can be found on the AASM website.

The Sleep Research Society (SRS) is pleased to offer Trainee Merit Awards that are based on abstract submissions. You can view the complete information on the SRS Website.

Continuing education credit will be provided to attendees of all oral abstracts presentations. All oral abstract presenters are required to review and adhere to the Conflict of Interest Disclosures policy listed below; authors of accepted poster presentation abstracts may disregard this information.

This activity, SLEEP 2021, has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Sleep Medicine (AASM) and the Associated Professional Sleep Societies, LLC (APSS). The American Academy of Sleep Medicine is accredited by the ACCME to provide continuing medical education for physicians.

In order to comply with the guidelines that must be followed to offer continuing education credit, all authors listed on accepted oral presentations must comply with the conflict of interest policy below. Authors of accepted poster presentations are not required to provide this information.

Conflict of Interest disclosures must be provided by March 15, 2021. Instructions for submission will be provided upon receipt of notification of acceptance. Speakers who have not completed their COI disclosure by this date may be replaced.

Conflict of Interest Policy

Prior to the activity, each speaker/author must disclose to their audience that the individual and their spouse (if applicable) have no relevant financial relationship(s) with a commercial interest OR have any relevant financial relations with a commercial interest.  The following information must be submitted for each speaker/author:

• The name(s) of any commercial interest(s) with which the individual and their spouse has relevant financial relationship(s) and the nature of the relationship(s); and
• A maximum of three (3) citations that reference the best available evidence in support of the topic.

Commercial interest(s) is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit, government organizations and non-health care related companies.

Relevant financial relationship(s) is defined as relationships in any amount occurring within the past 12 months that create a conflict of interest.

The nature of the relationship(s) is defined as financial relationships in which the individual or their spouse benefits by receiving income, salary, royalty, intellectual property rights, consulting fees, honoraria, or other financial benefits. Financial benefits are typically associated with roles such as employment, consulting, investigational or contract research, speaking/teaching, membership or advisory committees or review panels, board membership, and other activities from which compensation is received or expected.

Additionally, speakers cannot promote any commercial interests during their presentation. This includes, but may not be limited to, displaying logos and/or advertising in their presentations. Please keep in mind that commercial interests include educational events and materials from which an individual receives honoraria, travel reimbursement or royalties.

If a speaker/author does not comply with the APSS Conflict of Interest Policy, the speaker will not be permitted to participate in the program and may be banned from participating in future meetings. The APSS Program Committee will review the disclosures of financial relationships and citations to ensure compliance with the requirements stated above.

To comply with some requirements, a presentation outline may be requested from a speaker in advance of the meeting depending on their potential conflicts.

Speakers/authors will be required to disclose any relevant financial relationships with commercial interest verbally during their sessions. Further information and instructions will be provided to speakers/authors in advance of the meeting.